Live Quote · OTCLIPOHealthcare · Biotechnology

Lipella Pharmaceuticals Inc.

$0.00▲ 0.00%(+$0.00)

MKT CAP $2.31KLAST EARNINGS Sep 2, 2026

50%

Bullish

50%

Bullish

TickerSpark Score

59/100

▌ Mixed

73

Valuation

20

Profitability

90

Growth

84

Health

30

Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LIPO research report →

Analyst Price Target

$2.00+399900.0% vs. today

Range $2 – $2

Price Chart

-99.91% · this period

52-Week Range0% of range

Low

$0.00

Current

$0.00

High

$0.63

Float & Shares

Free Float: 93.7%
Shares Outstanding: 4.62M
Float Shares: 4.33M

Insider ActivityLast quarter

4 Buys2 Sells

Buy/sell ratio 2.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

Date	Insider	Role	Type	Shares	Value
Apr 3, 25	Kaufman Jonathan H	director, 10 percent owner, officer: See remarks below.	other	536,959	$536.96K
Apr 3, 25	Kaufman Jonathan H	director, 10 percent owner, officer: See remarks below.	other	4,060	$4.06K
Mar 13, 25	Kaufman Jonathan H	director, 10 percent owner, officer: See remarks below.	other	10,326	$10.33K
Mar 13, 25	Kaufman Jonathan H	director, 10 percent owner, officer: See remarks below.	other	4,060	$4.06K
Mar 10, 25	Kaufman Jonathan H	director, 10 percent owner, officer: See remarks below.	other	84,700	$84.70K
Mar 10, 25	Kaufman Jonathan H	director, 10 percent owner, officer: See remarks below.	other	28,924	$28.92K
Feb 28, 25	Kaufman Jonathan H	director, 10 percent owner, officer: See remarks below.	other	441,933	$441.93K
Feb 28, 25	Kaufman Jonathan H	director, 10 percent owner, officer: See remarks below.	other	125,833	$125.83K
Jan 15, 25	Kaufman Jonathan H	director, 10 percent owner, officer: See remarks below.	other	11,795	$11.79K
Jan 15, 25	Kaufman Jonathan H	director, 10 percent owner, officer: See remarks below.	other	303,041	$303.04K

A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.

Lipella Pharmaceuticals Inc.

Price Chart

About the company

Get TickerSpark's AI analysis on LIPO

Similar companies

Recent insider transactions

Our LIPO coverage

No research on LIPO yet